Nano-biotechnology deals with the study of biological and biochemical applications. Increase in demand for development of new inventions in medical industry, is driving the growth of nano-biotechnology market. The U.S. is adding fuel to the growth of this market by approving flexible policies for conducting research and development. The major factor influencing the growth for nano-biotechnology is investment in research and development. Government and private research institutes are avoiding investment in nano-biotechnological development; however, increase in demand for treatment on critical disease enhances the growth for this market.
Nano-biotechnology in collaboration with biological research leads to development of novel innovations in health care industry. This report provides current market trends for nano-biotechnology and future expected transitions in these trends. Market estimations in this report are based on primary and secondary research. In this report, an in depth intelligence is provided about the government regulation, and reimbursement policies.
Key players in the market include Aduro BioTech, Calando Pharmaceuticals Inc., Biosante Phosphate Pharmaceuticals Inc., Celgene Corporation, Elan Pharmaceuticals Inc., Flamel Technologies Inc., Nanophase Technologies Corporation, Sigma Aldrich Company, Dendritic Nanotechnologies Inc., SkyePharma Pharmaceuticals.
KEY MARKET SEGMENTS
GLOBAL MARKET, BY APPLICATIONS
GLOBAL MARKET, BY THERAPEUTICS
GLOBAL MARKET, BY GEOGRAPHIES